Mettler Toledo

MTD · NYSE · Healthcare · United States

Financials at a glance

Source: SEC XBRL

Annual

FY2023FY2024FY2025$3.8B$3.8B$3.9B$3.9B$4.0B$4.0B21.6% margin21.6% marginRevenueNet margin

Quarterly · last 8

Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26$925.9M$925.9M$946.8M$946.8M$954.5M$954.5M$883.7M$883.7M$983.2M$983.2M$1.0B$1.0B$947.1M$947.1M$1.0B$1.0B22.7% margin22.7% marginRevenueNet margin

Revenue (FY2025)

$4.0B

Net margin

21.6%

Revenue CAGR (2y)

+3.1%

Profit CAGR (2y)

+5.0%

EPS (FY2025)

42.05

Net profit (FY2025)

$869.2M

Ask MarketChacha about MTD

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

PeriodRevenueNet profitEPSNet margin
FY2025$4.0B$869.2M42.0521.6%
FY2024$3.9B$863.1M40.4822.3%
FY2023$3.8B$788.8M35.9020.8%

Quarterly

PeriodRevenueNet profitEPSNet margin
2026Q2$1.0B$232.9M11.5522.7%
2026Q1$947.1M$169.5M8.3317.9%
2025Q3$1.0B$217.5M10.5721.1%
2025Q2$983.2M$202.3M9.7620.6%
2025Q1$883.7M$163.6M7.8118.5%
2024Q3$954.5M$211.5M9.9622.2%
2024Q2$946.8M$221.8M10.3723.4%
2024Q1$925.9M$177.5M8.2419.2%
2023Q3$942.5M$201.6M9.2121.4%
2023Q2$982.1M$213.9M9.6921.8%
2023Q1$928.7M$188.4M8.4720.3%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.